Literature DB >> 17025251

Chemical stabilization of a Delta9-tetrahydrocannabinol prodrug in polymeric matrix systems produced by a hot-melt method: role of microenvironment pH.

Manish Munjal1, Mahmoud A ElSohly, Michael A Repka.   

Abstract

This research was conducted in order to fabricate stable polyethylene oxide (PEO)-based transmucosal systems of a Delta(9)-tetrahydrocannabinol (THC) prodrug, a hemisuccinate ester, using a hot-melt method. Since Delta(9)-tetrahydrocannabinol-hemisuccinate (THC-HS) was heat labile, a series of processing aids were evaluated in order to facilitate hot-melt production at lower temperatures, thereby reducing THC-HS degradation. The stability of THC-HS was influenced both by the processing conditions such as heating time and temperature, and the postprocessing storage conditions. The type of formulation additive also affected the extent of degradation. In the presence of polyethylene glycol (PEG)-400, the percentage of relative degradation of THC-HS to THC was 13.5% and 49.4% at 80 degrees C and 120 degrees C, respectively. In contrast, incorporation of vitamin E succinate (VES) reduced processing degradation to 2.1% and 9.2%, respectively, under the same conditions. Severe degradation of THC-HS was observed during storage, even under freezing conditions (-18 degrees C). A VES-Noveon AA-1 combination was observed to best stabilize the prodrug systems both during processing and postprocessing. Stabilization of THC-HS was achieved in these polyethylene oxide matrices at 4 degrees C, with almost 90% of theoretical drug remaining for up to 8 months. Investigation of the pH effect revealed that the pH of the microenvironment in these polymeric systems could be modulated to significantly improve the stability of THC-HS, degradation being the least in a relatively acidic medium.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17025251      PMCID: PMC2750513          DOI: 10.1208/pt070371

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  23 in total

1.  Characterization of physico-mechanical properties of indomethacin and polymers to assess their suitability for hot-melt extrusion processs as a means to manufacture solid dispersion/solution.

Authors:  Rina J Chokshi; Harpreet K Sandhu; Raman M Iyer; Navnit H Shah; A Waseem Malick; Hossein Zia
Journal:  J Pharm Sci       Date:  2005-11       Impact factor: 3.534

2.  Rectal bioavailability of delta-9-tetrahydrocannabinol from various esters.

Authors:  M A Elsohly; T L Little; A Hikal; E Harland; D F Stanford; L Walker
Journal:  Pharmacol Biochem Behav       Date:  1991-11       Impact factor: 3.533

3.  Rectal bioavailability of delta-9-tetrahydrocannabinol from the hemisuccinate ester in monkeys.

Authors:  M A ElSohly; D F Stanford; E C Harland; A H Hikal; L A Walker; T L Little; J N Rider; A B Jones
Journal:  J Pharm Sci       Date:  1991-10       Impact factor: 3.534

4.  Influence of plasticizers and drugs on the physical-mechanical properties of hydroxypropylcellulose films prepared by hot melt extrusion.

Authors:  M A Repka; T G Gerding; S L Repka; J W McGinity
Journal:  Drug Dev Ind Pharm       Date:  1999-05       Impact factor: 3.225

5.  Film coating theory and practice.

Authors:  G S Banker
Journal:  J Pharm Sci       Date:  1966-01       Impact factor: 3.534

6.  Characterization of cellulosic hot-melt extruded films containing lidocaine.

Authors:  Michael A Repka; Kavitha Gutta; Suneela Prodduturi; Manish Munjal; Steven P Stodghill
Journal:  Eur J Pharm Biopharm       Date:  2005-01       Impact factor: 5.571

7.  Plasma delta-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking.

Authors:  A Ohlsson; J E Lindgren; A Wahlen; S Agurell; L E Hollister; H K Gillespie
Journal:  Clin Pharmacol Ther       Date:  1980-09       Impact factor: 6.875

8.  Influence of storage conditions and type of plasticizers on ethylcellulose and acrylate films formed from aqueous dispersions.

Authors:  Paul W S Heng; L W Chan; K T Ong
Journal:  J Pharm Pharm Sci       Date:  2003 Sep-Dec       Impact factor: 2.327

9.  Bypassing the first-pass effect for the therapeutic use of cannabinoids.

Authors:  R D Mattes; L M Shaw; J Edling-Owens; K Engelman; M A Elsohly
Journal:  Pharmacol Biochem Behav       Date:  1993-03       Impact factor: 3.533

10.  Chemical stability of esters of nicotinic acid intended for pulmonary administration by liquid ventilation.

Authors:  Cheng-Hsuan Hsu; Michael Jay; Paul M Bummer; Hans-Joachim Lehmler
Journal:  Pharm Res       Date:  2003-06       Impact factor: 4.200

View more
  4 in total

1.  Preparation and characterization of inclusion complexes of a hemisuccinate ester prodrug of delta9-tetrahydrocannabinol with modified beta-cyclodextrins.

Authors:  Sampada B Upadhye; Swapnil J Kulkarni; Soumyajit Majumdar; Mitchell A Avery; Waseem Gul; Mahmoud A ElSohly; Michael A Repka
Journal:  AAPS PharmSciTech       Date:  2010-03-24       Impact factor: 3.246

2.  Influence of plasticizers on the stability and release of a prodrug of Delta(9)-tetrahydrocannabinol incorporated in poly (ethylene oxide) matrices.

Authors:  Sridhar Thumma; Mahmoud A ElSohly; Shuang-Qing Zhang; Waseem Gul; Michael A Repka
Journal:  Eur J Pharm Biopharm       Date:  2008-06-18       Impact factor: 5.571

3.  Chemical stability and bioadhesive properties of an ester prodrug of Delta 9-tetrahydrocannabinol in poly(ethylene oxide) matrices: effect of formulation additives.

Authors:  Sridhar Thumma; Soumyajit Majumdar; Mahmoud A ElSohly; Waseem Gul; Michael A Repka
Journal:  Int J Pharm       Date:  2008-07-05       Impact factor: 5.875

4.  Preformulation studies of a prodrug of Delta9-tetrahydrocannabinol.

Authors:  Sridhar Thumma; Soumyajit Majumdar; Mahmoud A Elsohly; Waseem Gul; Michael A Repka
Journal:  AAPS PharmSciTech       Date:  2008-08-28       Impact factor: 3.246

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.